Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Genmab
Eli Lilly and Company
Pfizer
AstraZeneca
Jazz Pharmaceuticals
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
AstraZeneca
Akeso
HonorHealth Research Institute
Alliance for Clinical Trials in Oncology
Taiho Oncology, Inc.
Children's Oncology Group
University Health Network, Toronto
Merck Sharp & Dohme LLC
Sun Yat-sen University
University of Southern California
Tesaro, Inc.
HonorHealth Research Institute
Eli Lilly and Company
Toray Industries, Inc
Eli Lilly and Company
Lisata Therapeutics, Inc.
Universitätsklinikum Hamburg-Eppendorf
National Cancer Institute (NCI)
Australasian Gastro-Intestinal Trials Group
Merck Sharp & Dohme LLC
University Hospital, Geneva
Samsung Medical Center
Seoul National University Hospital